Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham McIlroy

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of Hematology & Oncology|January 10, 2022
Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemiaHelen Parry, Graham McIlroy, Rachel Bruton, et al.
Blood|April 21, 2024
Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trialSridhar Chaganti, Shanna Maycock, Graham McIlroy, et al.
Leukemia Research|November 13, 2024
COVID-19 infection in adult and paediatric recipients of allogeneic stem cell transplantation: The UK experienceGiovanna Lucchini, Elena Cozma, Aimee Jackson, et al.
Blood Advances|August 31, 2021
A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma: the TIER trialChristopher P Fox, Ayesha S Ali, Graham McIlroy, et al.
Cancer Cell|May 19, 2022
COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemiaHelen Parry, Rachel Bruton, Thomas Roberts, et al.
The Lancet. Rheumatology|May 11, 2024
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trialCarl S Goodyear, Amit Patel, Eleanor Barnes, et al.
Blood|January 7, 2022
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patientsMatthew R Wilson, Toby A Eyre, Amy A Kirkwood, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of Hematology & Oncology|January 10, 2022
Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemiaHelen Parry, Graham McIlroy, Rachel Bruton, et al.
Blood|April 21, 2024
Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trialSridhar Chaganti, Shanna Maycock, Graham McIlroy, et al.
Leukemia Research|November 13, 2024
COVID-19 infection in adult and paediatric recipients of allogeneic stem cell transplantation: The UK experienceGiovanna Lucchini, Elena Cozma, Aimee Jackson, et al.
Blood Advances|August 31, 2021
A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma: the TIER trialChristopher P Fox, Ayesha S Ali, Graham McIlroy, et al.
Cancer Cell|May 19, 2022
COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemiaHelen Parry, Rachel Bruton, Thomas Roberts, et al.
The Lancet. Rheumatology|May 11, 2024
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trialCarl S Goodyear, Amit Patel, Eleanor Barnes, et al.
Blood|January 7, 2022
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patientsMatthew R Wilson, Toby A Eyre, Amy A Kirkwood, et al.
Pageof 4